This month’s healthcare and pharmaceutical headlines reflect increased scrutiny of public health decisions, regulatory actions, and funding priorities. Changes in advisory panels, shifts in government spending, and the adoption of new technologies influence how treatments are approved, funded, and perceived. These developments underscore the growing intersection of science, politics, and public opinion. As healthcare policy […]
